van Leeuwen FE - Search Results

1

Cancer risk after in utero exposure to diethylstilbestrol.

Boekel NB, Verloop J, van Boven HH, van Erp EJM, Schrijver L, Rookus MA, van Leeuwen FE. Boekel NB, et al. Among authors: van boven hh, van leeuwen fe, van erp ejm. Eur J Epidemiol. 2025 Jun;40(6):659-668. doi: 10.1007/s10654-025-01234-9. Epub 2025 May 28. Eur J Epidemiol. 2025. PMID: 40426001

2

The role of exogenous hormones in the epidemiology of breast, ovarian and endometrial cancer.

van Leeuwen FE, Rookus MA. van Leeuwen FE, et al. Eur J Cancer Clin Oncol. 1989 Dec;25(12):1961-72. doi: 10.1016/0277-5379(89)90378-7. Eur J Cancer Clin Oncol. 1989. PMID: 2698811 Review.

3

Oral contraceptives and risk of breast cancer in women aged 20-54 years. Netherlands Oral Contraceptives and Breast Cancer Study Group.

Rookus MA, van Leeuwen FE. Rookus MA, et al. Among authors: van leeuwen fe. Lancet. 1994 Sep 24;344(8926):844-51. doi: 10.1016/s0140-6736(94)92826-6. Lancet. 1994. PMID: 7916400

4

p53 protein overexpression in relation to risk factors for breast cancer.

van der Kooy K, Rookus MA, Peterse HL, van Leeuwen FE. van der Kooy K, et al. Among authors: van leeuwen fe. Am J Epidemiol. 1996 Nov 15;144(10):924-33. doi: 10.1093/oxfordjournals.aje.a008862. Am J Epidemiol. 1996. PMID: 8916503

5

Induced abortion and risk for breast cancer: reporting (recall) bias in a Dutch case-control study.

Rookus MA, van Leeuwen FE. Rookus MA, et al. Among authors: van leeuwen fe. J Natl Cancer Inst. 1996 Dec 4;88(23):1759-64. doi: 10.1093/jnci/88.23.1759. J Natl Cancer Inst. 1996. PMID: 8944006

6

Physical activity and breast cancer risk in women aged 20-54 years.

Verloop J, Rookus MA, van der Kooy K, van Leeuwen FE. Verloop J, et al. Among authors: van der kooy k, van leeuwen fe. J Natl Cancer Inst. 2000 Jan 19;92(2):128-35. doi: 10.1093/jnci/92.2.128. J Natl Cancer Inst. 2000. PMID: 10639514

7

Risk of cervical intra-epithelial neoplasia and invasive cancer of the cervix in DES daughters.

Verloop J, van Leeuwen FE, Helmerhorst TJM, de Kok IMCM, van Erp EJM, van Boven HH, Rookus MA. Verloop J, et al. Among authors: van boven hh, van leeuwen fe, van erp ejm. Gynecol Oncol. 2017 Feb;144(2):305-311. doi: 10.1016/j.ygyno.2016.11.048. Epub 2016 Dec 7. Gynecol Oncol. 2017. PMID: 27939984 Free article.

8

Cardiovascular disease risk after breast cancer treatment in patients with a BRCA1/2 pathogenic variant.

Terra L, Boekel NB, Hooning MH, Collee M, Schmidt MK, Adank MA, Kok M, Aleman BMP, Jager A, Sattler MGA, Maas AHEM, Schaapveld M, van Leeuwen FE. Terra L, et al. Among authors: van leeuwen fe. Breast Cancer Res Treat. 2025 Feb;209(3):573-583. doi: 10.1007/s10549-024-07516-2. Epub 2024 Oct 31. Breast Cancer Res Treat. 2025. PMID: 39482556

9

Differences in breast cancer risk factors to neu (c-erbB-2) protein overexpression of the breast tumor.

Treurniet HF, Rookus MA, Peterse HL, Hart AA, van Leeuwen FE. Treurniet HF, et al. Among authors: van leeuwen fe. Cancer Res. 1992 Apr 15;52(8):2344-5. Cancer Res. 1992. PMID: 1348449

10

[Settlement effected for damages for victims of diethylstilbestrol (DES)].

van Erp EJ, Heintz AP, Helmerhorst TJ, Koster ME, van Leeuwen FE. van Erp EJ, et al. Among authors: van leeuwen fe. Ned Tijdschr Geneeskd. 2007 May 26;151(21):1197-200. Ned Tijdschr Geneeskd. 2007. PMID: 17557761 Dutch.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters